These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Possible induction of West syndrome by oxcarbazepine therapy in a patient with complex partial seizures. Veerapandiyan A, Singh P, Mikati MA. Epileptic Disord; 2012 Mar; 14(1):99-103. PubMed ID: 22425652 [Abstract] [Full Text] [Related]
10. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy. Vendrame M, Khurana DS, Cruz M, Melvin J, Valencia I, Legido A, Kothare SV. Epilepsia; 2007 Nov; 48(11):2116-20. PubMed ID: 17645535 [Abstract] [Full Text] [Related]
13. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience. Bourgeois BF, D'Souza J. Epilepsy Behav; 2005 Nov; 7(3):375-82. PubMed ID: 16176888 [Abstract] [Full Text] [Related]
16. Oxcarbazepine in the treatment of early childhood epilepsy. Gaily E, Granström ML, Liukkonen E. J Child Neurol; 1997 Nov; 12(8):496-8. PubMed ID: 9430314 [Abstract] [Full Text] [Related]
17. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children. Holtmann M, Krause M, Opp J, Tokarzewski M, Korn-Merker E, Boenigk HE. Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784 [Abstract] [Full Text] [Related]